Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04594096 · ClinicalTrials.gov registry record · NA

Improving Treatment-Related Symptom Management in Adolescents and Young Adults With Cancer

A NA study of Cancer, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04594096 is a NA study of Cancer that has completed, run by University of California, Davis. The registered enrollment target is 20 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04594096, a NA study of Cancer, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study will test the acceptability and feasibility of a telehealth intervention to improve communication between patients and medical providers in adolescent and young adult (AYA) cancer patients receiving chemotherapy treatment.

Conditions Studied

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL Telehealth visits

Study Locations (1)

California

  • Comprehensive Cancer Center - Sacramento

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-09-30
Est. Completion 2023-12-31
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT04594096

The ClinicalTrials.gov registry entry for NCT04594096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT04594096 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04594096 about?

NCT04594096 is a clinical study titled "Improving Treatment-Related Symptom Management in Adolescents and Young Adults With Cancer". This study will test the acceptability and feasibility of a telehealth intervention to improve communication between patients and medical providers in adolescent and young adult (AYA) cancer patients receiving chemotherapy treatment.

What is the current status of trial NCT04594096?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-09-30. Estimated completion is 2023-12-31.

What conditions does trial NCT04594096 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT04594096?

The interventions under investigation include: Standard of Care (BEHAVIORAL), Telehealth visits (BEHAVIORAL).

Who is sponsoring clinical trial NCT04594096?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04594096 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.